Hepatitis C in Children-An Asia-Pacific Concise Perspective

Area of Science:

• Hepatology
• Virology
• Public Health

Background:

• Hepatitis C virus (HCV) was discovered in 1989.
• Curative direct-acting antiviral (DAA) therapies are now available.
• HCV eradication is a potential global health goal.

Purpose of the Study:

• To outline the management approach for children with HCV in the Asia-Pacific region.
• To identify challenges and complexities in pediatric HCV management and eradication efforts within this region.

Main Methods:

• Review of current pediatric HCV management strategies.
• Analysis of implementation barriers for DAA therapy in the Asia-Pacific context.
• Synthesis of regional data on HCV transmission and treatment access for children.

Main Results:

• DAA therapies offer high cure rates for pediatric HCV.
• Significant challenges exist in diagnosis, access to treatment, and sustained follow-up for children.
• Regional disparities in healthcare infrastructure impact eradication feasibility.

Conclusions:

• While curative treatments exist, achieving HCV eradication in children across the Asia-Pacific region requires addressing significant implementation hurdles.
• Tailored strategies are needed to improve access to diagnosis and DAA therapy for pediatric populations.
• Multifaceted approaches involving healthcare providers, policymakers, and public health initiatives are crucial for pediatric HCV elimination.